v3.26.1
Business Combination - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 04, 2026
Jun. 30, 2026
Jun. 30, 2026
Jun. 30, 2025
Business Combination [Line Items]        
Contingent consideration   $ 2,437 $ 2,437  
Initial cash purchase price, net of cash acquired $ 11,200   11,150 $ 0
Non-cash gain from settlement     3,858 $ 0
UK Biocentre        
Business Combination [Line Items]        
Purchase price, net of cash acquired 27,474   27,500  
Contingent consideration 2,483      
Initial cash purchase price, net of cash acquired 11,150      
Non-cash gain from settlement     3,900  
Transaction expense paid 133   13,800  
Estimated fair value of contingent consideration $ 2,500      
Liability   2,500 $ 2,500  
Increase in operating lease right-of-use asset   $ 4,000    
UK Biocentre | Trademarks        
Business Combination [Line Items]        
Estimated useful life 7 years